Table 3.
Sex (Male vs. Female) | Total (n = 120) | Male (n = 32) | Female (n = 88) | p value |
---|---|---|---|---|
Age | 35.7 ± 17.5 | 33.3 ± 16.9 | 36.55 ± 17.7 | 0.345 |
TIgE(+):TIge(−) | 69:51 (57.5%:42.5%) | 27:5 (84.4%:15.6%) | 42:46 (47.7%:52.3%) | <0.001 |
SIgE(+):SIge(−) | 83:37 (69.2%:30.8%) | 26:6 (81.2%:18.8%) | 57:31 (64.8%:35.2%) | 0.084 |
AIgE(+):AIge(−) | 93:27 (77.5%:22.5%) | 31:1 (96.9%:3.1%) | 62:26 (70.5%:29.5%) | 0.001 |
Age (young vs. old) | Total (n = 120) | Young group (n = 70) | Old group (n = 50) | p value |
Sex (male:female) | 32:88 | 20:50 | 12:38 | 0.577 |
TIgE(+): TIge(−) | 69:51 (57.5%:42.5%) | 45:25 (64.3%:35.7%) | 24:26 (48.0%:52.0%) | 0.075 |
SIgE(+): SIge(−) | 83:37 (69.2%:30.8%) | 54:16 (77.1%:22.9%) | 29:21 (58.0%:42.0%) | 0.025 |
AIgE(+):AIge(−) | 93:27 (77.5%:22.5%) | 58:12 (82.9%:17.1%) | 35:15 (70.0%:30.0%) | 0.096 |
TIgE, serum total immunoglobulin E; SIgE, serum specific immunoglobulin E; AIgE(+), positive for at least one of TIgE and SIgE; AIgE(−), negative for both TIgE and SIgE.